| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2567.1998.00442.X |
| P8608 | Fatcat ID | release_nxfchrzktzanfjdcie436car3a |
| P698 | PubMed publication ID | 9640246 |
| P5875 | ResearchGate publication ID | 13644893 |
| P2093 | author name string | M Jondal | |
| S C Chow | |||
| L M Osorio | |||
| M Rottenberg | |||
| P2860 | cites work | Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand | Q24319426 |
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Two-step TCR zeta/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases | Q30194389 | ||
| CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines | Q33838538 | ||
| CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. | Q34300766 | ||
| T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression | Q34553481 | ||
| Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells | Q36364656 | ||
| Role of the CD28 receptor in T-cell activation | Q37881494 | ||
| Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28 | Q38336999 | ||
| Differential effects of staurosporine analogues on cell cycle, growth and viability in A549 cells | Q40027086 | ||
| Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice | Q40404888 | ||
| Cyclosporin A, FK506 and rapamycin: more than just immunosuppression | Q40492144 | ||
| PI 3-kinase: a pivotal pathway in T-cell activation? | Q41166743 | ||
| Responses of T cells to ligands for the T-cell receptor | Q41207462 | ||
| CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase | Q41270812 | ||
| Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation | Q41354263 | ||
| Characterization of a CD6 ligand(s) expressed on human- and murine-derived cell lines and murine lymphoid tissues | Q41435596 | ||
| The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation | Q41486132 | ||
| Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. | Q41577630 | ||
| Physical association of CD4 with the T cell receptor | Q41640150 | ||
| CD28 ligation in T-cell activation: evidence for two signal transduction pathways | Q41739170 | ||
| Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells | Q44991185 | ||
| Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. | Q54354974 | ||
| Activation of CD3/TCR negative human thymocytes via CD28 molecule | Q68242675 | ||
| Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation | Q69124858 | ||
| Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes | Q69753099 | ||
| 2H1--a novel antigen involved in T lymphocyte triggering | Q69915295 | ||
| Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein | Q72094475 | ||
| Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex | Q72117192 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 358-365 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells | |
| P478 | volume | 93 |
| Q56959435 | A major quantitative trait locus for CD4–CD8 ratio is located on chromosome 11 |
| Q57816679 | Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells |
| Q34337963 | CD6 as a therapeutic target in autoimmune diseases: successes and challenges. |
| Q38341487 | CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction |
| Q45721862 | Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse |
| Q34209993 | Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms |
| Q24298706 | Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells |
| Q38730494 | Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases |
| Q24300571 | Relevance of CD6-mediated interactions in T cell activation and proliferation |
| Q34163553 | The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells |
Search more.